Target intelligence / Profile preview

Ambler class A β-lactamase (Class A β-lactamase)

Target
Class A β-lactamase
Molecular classification
Enzyme
01

Overview

Ambler class A β-lactamases are serine-based enzymes produced by bacteria that hydrolyze the β-lactam ring in antibiotics such as penicillins, cephalosporins, and monobactams, conferring resistance to these drugs. They are defined by molecular homology in the Ambler classification system, which groups them separately from classes B (metallo), C, and D based on amino acid sequence and active site serine residue. Common examples include plasmid-encoded ESBLs like TEM, SHV, and CTX-M, primarily in Enterobacterales such as Escherichia coli and Klebsiella pneumoniae, as well as carbapenemases like KPC. These enzymes inactivate extended-spectrum cephalosporins and other β-lactams but are typically inhibited by compounds like clavulanate or avibactam when combined with antibiotics. In disease, they drive multidrug-resistant infections, complicating treatment of Gram-negative bacterial infections in clinical settings. Targeting them therapeutically involves β-lactam/β-lactamase inhibitor combinations to restore antibiotic susceptibility.

Other names
Extended-spectrum β-lactamases (ESBLs)Serine β-lactamases (class A)TEM β-lactamasesSHV β-lactamasesCTX-M β-lactamasesKPC (Klebsiella pneumoniae carbapenemase)
02

Mechanism of action

Serine-based hydrolysis of β-lactam ring. Inhibition by β-lactamase inhibitors forming stable acyl-enzyme complex.

03

Biological functions

Hydrolysis of β-lactam antibiotics
04

Disease associations

Infection (antibiotic resistance)
05

Safety considerations

Emergence of resistance due to plasmid-mediated spreadReduced efficacy of β-lactam antibiotics in infections
06

Interacting drugs

Penicillins (e.g., piperacillin, ampicillin)

4 more in the full profile.

Beyond the preview

Go deeper on Ambler class A β-lactamase (Class A β-lactamase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ambler class A β-lactamase (Class A β-lactamase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call